For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Autonomic Technologies, Inc.

USPTO Granted Patents = 25

EPO Patents = 3

Trademarks = 3

Forward Citations = 350

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Benjamin D Pless (18 out of 118 patents)

Anthony V Caparso (16 out of 84 patents)

Carl Lance Boling (10 out of 28 patents)

4. Ryan Powell (7 out of 9 patents)

5. Francis A Papay (3 out of 35 patents)

6. Morgan Clyburn (3 out of 4 patents)

7. Jennifer Teng (3 out of 9 patents)

8. Karen Tsuei (2 out of 3 patents)

9. Kellie S Fletcher (2 out of 2 patents)

10. Amy Michelle Goodman (2 out of 11 patents)

11. Kenneth N Horne (1 out of 37 patents)

12. Barbara Gibb (1 out of 21 patents)

13. Patrick Hard (1 out of 1 patent)

14. Mike Hardage (1 out of 1 patent)

15. Brinda Ramachandran (1 out of 1 patent)

25 patents: Sort by Forward Citations

1. 10286213 - Neurostimulator system, apparatus, and method (2019-05-14),

2. 10137312 - Methods of improving a patients recovery after a neuro-ischemic event (2018-11-27),

3. 10105091 - Methods of using nerve evoked potentials to monitor a surgical procedure (2018-10-23),

4. 10098662 - Surgical tools to facilitate delivery of a neurostimulator into the pterygopalatine fossa (2018-10-16),

5. 9861295 - System and method for surgical planning and navigation to facilitate placement of a medical device within a target region of a patient (2018-01-09),

6. 9757572 - Implantable medical device and method for laser processing (2017-09-12),

7. 9700721 - Stimulation method for treatment of ocular conditions (2017-07-11),

8. 9662140 - Surgical guidance tool to facilitate delivery of a neurostimulator into a pterygopalatine fossa (2017-05-30),

9. 9610441 - Stimulation method for treatment of dermatological conditions (2017-04-04),

10. 9607195 - Patient identification system (2017-03-28),

11. 9604057 - Stimulation method for a sphenopalatine ganglion, sphenopalatine nerve, vidian nerve, or branch thereof for treatment of medical conditions (2017-03-28),

12. 9554694 - Integrated delivery and visualization tool for a neuromodulation system (2017-01-31),

13. 9456836 - Apparatus and method for delivering a neurostimulator into the pterygopalatine fossa (2016-10-04),

14. 9364671 - Neuromodulation to treat menopause-related conditions (2016-06-14),

15. 9320908 - Approval per use implanted neurostimulator (2016-04-26),

Autonomic Technologies, Inc. (ATI) is a medical device company that specializes in developing and commercializing innovative neuromodulation technologies. Founded in 2002, ATI has focused on creating therapeutic solutions for patients suffering from severe headache and migraine. The company's flagship product is the ATI Neurostimulation System, an implantable device that delivers occipital nerve stimulation to provide long-term relief from chronic migraines. With a commitment to improving the quality of life for patients, ATI continues to explore new applications for neuromodulation technology in the field of chronic pain management.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

25 Patents

#76 in Redwood City, CA

#3,056 in California

#12,903 in US

#24,910 in the World

Redwood City, CA, United States of America

Autonomic Technologies, Inc.

Forward Citations = 350

21 inventors:

Benjamin D Pless (18 out of 118 patents)

Anthony V Caparso (16 out of 84 patents)

Carl Lance Boling (10 out of 28 patents)

4. Ryan Powell (7 out of 9 patents)

5. Francis A Papay (3 out of 35 patents)

Please report any incorrect information to support@idiyas.com

Loading…